一種新型軟件運算法則使用了一種人工智能以及神經網絡，并同時使用脈搏血氧測定儀，來檢測阻塞性睡眠暫停(OSA)和潮式呼吸（Cheyne-Stokes呼吸，CSR）。

這種技術是根據213項睡眠研究中血氧測定儀記錄到的分析結果而開發的。已經證實這套軟件在診斷OSA和CSR方面具有極高的敏感性和特異性。這項技術是由美國布法羅大學醫學與生物醫學科學院(UB, NY, USA)研制開發的。OSA僅僅在美國就影響了180萬人，同時還有90％患者沒有診斷出來。

布法羅大學已經與Sleep解決方案公司(Annapolis, MD, USA)簽訂了一項協議，將這種新型檢測技術進行商品化并投放市場。Sleep公司為這項新技術提供在家庭內的診斷、治療以及監護睡眠呼吸疾病（尤其式OSA）的服務。

根據布法羅大學研究部臨時副總裁 兼布法羅大學科學辦公室主任Robert J. Genco的說法，“在全球范圍的臨床實踐中，對阻塞性睡眠暫停與潮式呼吸的診斷，迫切需要一種價廉物美的方法。我們十分自信Sleep公司將能夠把這種嶄新的技術投向市場，從而為大眾的需要提供低成本的操作簡便的診斷公斤?！?BR> 
New Testing Technology for Sleep Apnea
 
A new software algorithm uses a form of artificial intelligence, a neural network, to detect (OSA) and Cheyne-Stokes respiration (CSR), along with a pulse oximetry signal.

The technology is based on the analysis of the oximetric recordings of 213 sleep studies. The software has demonstrated very high sensitivities and specificities for diagnosing OSA and CSR.

The technology was developed at the University of Buffalo School of Medicine and Biomedical Sciences (UB, NY, USA). OSA affects 18 million people in the United States alone, with as many as 90% going undiagnosed.

The University of Buffalo has signed an agreement with Sleep Solutions, Inc. (Annapolis, MD, USA) to commercialize and distribute the new testing technology. Sleep Solutions provides technology and testing services for at-home diagnosis, therapy, and care of sleep-disordered breathing, particularly OSA.

According to Robert J. Genco, UB interim vice president for research and director of the UB Office of Science, there is “a growing worldwide clinical need to provide a cost-effective solution for diagnosis of obstructive sleep apnea and Cheyne-Stokes respiration. We are very confident that Sleep Solutions will be able to bring this novel technology to the marketplace resulting in a lower-costing, easier-to-implement diagnostic tool for the public good.”